SevoFlo
sevoflurane
Table of contents
Overview
An overview of SevoFlo and why it is authorised in the EU.
This EPAR was last updated on 29/03/2021
Authorisation details
Product details | |
---|---|
Name |
SevoFlo
|
Agency product number |
EMEA/V/C/000072
|
Active substance |
sevoflurane
|
International non-proprietary name (INN) or common name |
sevoflurane
|
Species |
|
Anatomical therapeutic chemical veterinary (ATCvet) codes |
QN01AB08
|
Publication details | |
---|---|
Marketing-authorisation holder |
Zoetis Belgium SA
|
Revision |
18
|
Date of issue of marketing authorisation valid throughout the European Union |
11/12/2002
|
Contact address |
Rue Laid Burniat 1 |
Product information
19/03/2021 SevoFlo - EMEA/V/C/000072 - IA/0024
This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.
Product information documents contain:
- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).
You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.
Pharmacotherapeutic group
Pharmacotherapeutic group
Anesthetics, general
Therapeutic indication
Therapeutic indication
For the induction and maintenance of anaesthesia in dogs and cats.